23rd Sep 2024 Plain language summary of the BICSTaR study: one-year results of bictegravir, emtricitabine, and tenofovir alafenamide for HIV treatment
6th Sep 2024 A plain-language summary of two 5-Year studies on bictegravir/emtricitabine/tenofovir alafenamide in people with HIV
